Latest Parker Waichman LLP Stories
A former U.S.
Defense motion granted in a case that is part of a mass tort litigation brought over Janssen Pharmaceutical’s antipsychotic medication, Risperdal. Port Washington,
The 9/11 fund has approved payments of $804 million to 3,100 claimants who suffered adverse health effects as a result of the 2001 attacks.
The bellwether case was the first federal lawsuit to reach trial within seven multidistrict litigations brought over the surgical devices used to treat specific gynecological conditions.
The U.S. Supreme Court has denied a petition submitted by Teva Pharmaceuticals USA Inc. in which the generic drug maker sought to challenge a lawsuit brought over generic drug injuries.
Following at least two deaths in 2014, federal regulators, one United States senator, and a trade organization recommend consumers avoid caffeine powder, according to a Pittsburgh Post-Gazette
The September 11th VCF Special Master, Sheila Birnbaum, has released updated statistics regarding the progress of the fund and compensation determinations.
New York City Council members have joined efforts to reauthorize the Zadroga Act, which provides compensation and medical treatment funds to first responders and rescue workers injured due to
The litigation brought over the Johnson & Johnson subsidiary’s all-metal hip device continues to proceed with an Order for an open court conference. Port
Use of power morcellation devices during some minimally invasive gynecological procedures has been associated with increased risks of spreading hidden cancers, in some cases, months following
- Withering but not falling off, as a blossom that persists on a twig after flowering.